Cayla McKernan practices in plastic and reconstructive surgery at Memorial Sloan Kettering Cancer Center in New York, N.Y. The author has disclosed no potential conflicts of interest, financial or otherwise.
JAAPA. 2021 Apr 1;34(4):47-51. doi: 10.1097/01.JAA.0000735780.35691.e5.
Each year, hundreds of thousands of women undergo aesthetic or reconstructive breast implant surgery. Clinicians and patients must be aware of the benefits and risks of this surgery. Recently, the FDA suggested a recall of certain textured breast implants because of a link between these implants and a rare form of lymphoma, now referred to as breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). This malignancy has an indolent course and an excellent prognosis when detected and treated early. This article reviews BIA-ALCL, addresses public safety advisories, and emphasizes protocol that all clinicians should follow when encountering a patient with textured breast implants.
每年都有成千上万的女性接受美容或重建乳房植入手术。临床医生和患者必须了解这种手术的好处和风险。最近，FDA 建议召回某些纹理乳房植入物，因为这些植入物与一种罕见的淋巴瘤之间存在关联，现在称为乳房植入物相关间变性大细胞淋巴瘤（BIA-ALCL）。这种恶性肿瘤在早期发现和治疗时具有惰性病程和极好的预后。本文回顾了 BIA-ALCL，讨论了公共安全建议，并强调了所有临床医生在遇到有纹理乳房植入物的患者时应遵循的方案。
